Inovio to develop COVID-19 DNA-encoded monoclonal antibodies

By The Science Advisory Board staff writers

December 15, 2020 -- Inovio, along with a team of scientists from the Wistar Institute, AstraZeneca, the University of Pennsylvania, and Indiana University, has received a $37.6 million grant from the Defense Advanced Research Projects Agency, a branch of the U.S. Department of Defense, to develop COVID-19 treatments.

The grant is for the use of Inovio's DNA-encoded monoclonal antibody (dMAb) technology to develop anti-SARS-CoV-2-specific dMAbs, which could function as both a therapeutic and preventive treatment for COVID-19.

The public-private partnership means Inovio can not only broaden the scope and application of its DNA medicines, but also open the door for better patient administration and more cost-effective, scalable production of monoclonal antibody products for other infectious diseases and cancers, the firm said.

Under the two-year grant, Inovio and Wistar will construct COVID-19 dMAb candidates mirroring AstraZeneca's traditional recombinant monoclonal antibody candidates that are currently being tested in clinical trials. The dMAb candidates can be developed and produced in vivo, which offers a cost-effective and scalable therapeutic option, the firm said.

Afterward, the dMAb candidates will be advanced into preclinical studies and then into first-in-human clinical trials within one year of funding.


Copyright © 2020 scienceboard.net
 
To access all The ScienceBoard content create a free account now:


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.


Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.

Already have an account? Sign in here